Finance

Lists
TRAW:NASDAQ
Traws Pharma Inc
$0.56
+5.66%
(+0.030) 1D
$0.55
-1.54% (-0.0086)
After hours
Closed: Aug 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRAW...
Open
$0.56
High
$0.56
Low
$0.53
Mkt. cap
8.61M
Avg. vol.
117.17K
Volume
76.34K
52-wk high
$3.25
52-wk low
$0.43
EPS
-$1.62
Beta
1.57
Shares outstanding
15.37M
No. of employees
6
Open
$0.56
High
$0.56
Low
$0.53
Mkt. cap
8.61M
Avg. vol.
117.17K
Volume
76.34K
52-wk high
$3.25
52-wk low
$0.43
EPS
-$1.62
Beta
1.57
Shares outstanding
15.37M
No. of employees
6
News stories
From web sources and news partners
About Traws Pharma Inc
CEO-
Employees6
Founded1998
Headquarters-
SectorPharmaceutical industry
Websitetrawspharma.com
Analyst ratings
Based on 2 analysts giving stock ratings to TRAW in the past 3 months
Hold
Buy
0
Hold
2
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for TRAW in the last 3 months.
Highest
Current $0.56
$1.00 (+78.57%)
Average
$1.00 (+78.57%)
Lowest
$1.00 (+78.57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Hold
Reiterated
$1.00
+78.6%
08/18/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Hold
Downgraded
-
-
06/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.31M
5.04M
4.91M
1.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.74M
2.33M
2.03M
3.48M
Operating expense
4.06M
7.37M
6.95M
3.18M
Total operating expenses
4.06M
7.37M
6.95M
3.18M
Operating income
-4.06M
-7.37M
-6.95M
-3.18M
Other non operating income
93.00K
-553.00K
-161.00K
121.00K
EBT including unusual items
-3.96M
-7.44M
-7.11M
-3.05M
EBT excluding unusual items
-3.96M
-7.44M
-7.11M
-3.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-1.40M
Net income
-3.96M
-7.44M
-7.11M
-3.05M
Net profit margin
-
-
-
-
Earnings per share
-
-0.55
-0.52
-0.18
Interest and investment income
-
455.00K
-
-
Interest expense
-
-
-
-
Net interest expenses
-
455.00K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.04M
-7.32M
-6.90M
-3.13M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps